Chinese english Germany Japanese Korea

Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester

Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester Struktur
1932508-77-4
CAS-Nr.
1932508-77-4
Englisch Name:
Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
Synonyma:
tert-Butyl ((3R,4S)-4-methoxypyrrolidin-3-yl)carbamate;Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
CBNumber:
CB14186002
Summenformel:
C10H20N2O3
Molgewicht:
216.28
MOL-Datei:
1932508-77-4.mol
Request For Quotation

Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester Eigenschaften

Siedepunkt:
314.5±42.0 °C(Predicted)
Dichte
1.07±0.1 g/cm3(Predicted)
pka
11.71±0.40(Predicted)

Sicherheit

Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd. 		+86-512-68323658 +86-18168183658
 sales1@artkmedchem.com China 39010 58
Jiangsu yize medical technology co. LTD 18962082606
 3394205705@qq.com China 1751 58
Jiangsu yize medical technology co. LTD 18550739526
 23903480@qq.com China 5841 58
Jiangsu yize medical technology co. LTD 18962082606
 3394205705@qq.com China 9897 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
 malulu@leyan.com China 54986 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
 sales_china@pharmablock.com China 9792 58
  • Carbamic acid, N-[(3R,4S)-4-methoxy-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
  • tert-Butyl ((3R,4S)-4-methoxypyrrolidin-3-yl)carbamate
  • 1932508-77-4
Copyright 2019 © ChemicalBook. All rights reserved